These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 22428994)
41. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. Kohane DS; Tse JY; Yeo Y; Padera R; Shubina M; Langer R J Biomed Mater Res A; 2006 May; 77(2):351-61. PubMed ID: 16425240 [TBL] [Abstract][Full Text] [Related]
42. Preparation and optimization of monodisperse polymeric microparticles using modified vibrating orifice aerosol generator for controlled delivery of letrozole in breast cancer therapy. Alemrayat B; Elrayess MA; Alany RG; Elhissi A; Younes HM Drug Dev Ind Pharm; 2018 Dec; 44(12):1953-1965. PubMed ID: 30035646 [TBL] [Abstract][Full Text] [Related]
43. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid. Silva EL; Carneiro G; Caetano PA; Goulart G; Ferreira Costa D; de Souza-Fagundes EM; Gomes DA; Ferreira LA Expert Rev Anticancer Ther; 2015 Feb; 15(2):247-56. PubMed ID: 25611812 [TBL] [Abstract][Full Text] [Related]
44. Protein instability in poly(lactic-co-glycolic acid) microparticles. van de Weert M; Hennink WE; Jiskoot W Pharm Res; 2000 Oct; 17(10):1159-67. PubMed ID: 11145219 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of 3-D tumor spheroids by timed-released hydrophilic and hydrophobic drugs from multilayered polymeric microparticles. Lee WL; Guo WM; Ho VH; Saha A; Chong HC; Tan NS; Widjaja E; Tan EY; Loo SC Small; 2014 Oct; 10(19):3986-96. PubMed ID: 24947558 [TBL] [Abstract][Full Text] [Related]
46. Electrospraying technique for the fabrication of metronidazole contained PLGA particles and their release profile. Prabhakaran MP; Zamani M; Felice B; Ramakrishna S Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():66-73. PubMed ID: 26249566 [TBL] [Abstract][Full Text] [Related]
47. Development and characterization of skin permeation retardants and enhancers: a comparative study of levothyroxine-loaded PNIPAM, PLA, PLGA and EC microparticles. Azarbayjani AF; Khu JV; Chan YW; Chan SY Biopharm Drug Dispos; 2011 Oct; 32(7):380-8. PubMed ID: 21815171 [TBL] [Abstract][Full Text] [Related]
48. Engineering polymeric microparticles as theranostic carriers for selective delivery and cancer therapy. Win KY; Ye E; Teng CP; Jiang S; Han MY Adv Healthc Mater; 2013 Dec; 2(12):1571-5. PubMed ID: 23712912 [TBL] [Abstract][Full Text] [Related]
49. Mathematical modeling of PLGA microparticles: from polymer degradation to drug release. Casalini T; Rossi F; Lazzari S; Perale G; Masi M Mol Pharm; 2014 Nov; 11(11):4036-48. PubMed ID: 25230105 [TBL] [Abstract][Full Text] [Related]
50. Effect of agitation regimen on the in vitro release of leuprolide from poly(lactic-co-glycolic) acid microparticles. Schoubben A; Blasi P; Deluca PP J Pharm Sci; 2012 Mar; 101(3):1212-20. PubMed ID: 22189694 [TBL] [Abstract][Full Text] [Related]
51. A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways. Yang D; Luo W; Wang J; Zheng M; Liao XH; Zhang N; Lu W; Wang L; Chen AZ; Wu WG; Liu H; Wang SB; Zhou XZ; Lu KP J Control Release; 2018 Jan; 269():405-422. PubMed ID: 29170140 [TBL] [Abstract][Full Text] [Related]
52. Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro. Zhang H; Gao S Int J Pharm; 2007 Feb; 329(1-2):122-8. PubMed ID: 17000068 [TBL] [Abstract][Full Text] [Related]
54. A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer. Narvekar M; Xue HY; Tran NT; Mikhael M; Wong HL Eur J Pharm Biopharm; 2014 Sep; 88(1):226-37. PubMed ID: 24816129 [TBL] [Abstract][Full Text] [Related]
55. A one-step electrospray-based technique for modulating morphology and surface properties of poly(lactide-co-glycolide) microparticles using Pluronics®. Seth A; Katti DS Int J Nanomedicine; 2012; 7():5129-36. PubMed ID: 23055725 [TBL] [Abstract][Full Text] [Related]
56. Biodegradable poly (DL-lactide glycolide) microparticles as a vehicle for allergen-specific vaccines: a study performed with Ole e 1, the main allergen of olive pollen. Batanero E; Barral P; Villalba M; Rodríguez R J Immunol Methods; 2002 Jan; 259(1-2):87-94. PubMed ID: 11730844 [TBL] [Abstract][Full Text] [Related]
57. Protein-loaded PLGA microparticles engineered by flow focusing: physicochemical characterization and protein detection by reversed-phase HPLC. Holgado MA; Cózar-Bernal MJ; Salas S; Arias JL; Alvarez-Fuentes J; Fernández-Arévalo M Int J Pharm; 2009 Oct; 380(1-2):147-54. PubMed ID: 19635540 [TBL] [Abstract][Full Text] [Related]
58. Effects of poloxamer 188 on the characteristics of poly(lactide-co-glycolide) nanoparticles. Chae JM; Mo SM; Oh IJ J Nanosci Nanotechnol; 2010 May; 10(5):3224-7. PubMed ID: 20358927 [TBL] [Abstract][Full Text] [Related]
59. Poly (D,L-lactic-co-glycolide) nanoparticles for the improved therapeutic efficacy of all-trans-retinoic acid: a study of acute myeloid leukemia (AML) cell differentiation in vitro. Simon AM; Jagadeeshan S; Abraham E; Akhilandeshwaran A; Pillai JJ; Kumar NA; Sivakumari AN; Kumar GS Med Chem; 2012 Sep; 8(5):805-10. PubMed ID: 22741806 [TBL] [Abstract][Full Text] [Related]
60. Magnetically responsive polymeric microparticles for oral delivery of protein drugs. Cheng J; Teply BA; Jeong SY; Yim CH; Ho D; Sherifi I; Jon S; Farokhzad OC; Khademhosseini A; Langer RS Pharm Res; 2006 Mar; 23(3):557-64. PubMed ID: 16388405 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]